(Q40473110)

20 September 2017

1 reference

title

Treatment of essential thrombocythemia with anagrelide. (English)

1 reference

20 September 2017

M M Chintagumpala

1

1 reference

20 September 2017

L L Kennedy

series ordinal

2

1 reference

20 September 2017

C P Steuber

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

The Journal of Pediatrics

20 September 2017

published in

1 reference

20 September 2017

volume

127

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

495-498

1 reference

Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Thrombocytosis in pediatric outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Alpha-interferon therapy for essential thrombocythaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Long-term interferon therapy for thrombocytosis in myeloproliferative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Anagrelide: A New Drug for Treating Thrombocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

Essential thrombocythemia in a child: management with anagrelide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Essential thrombocythemia and leukemic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970090-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(95)70090-0

1 reference

20 September 2017

1 reference